StreetAlpha
13F holdings · Q3 2026

Virtus Investment Advisers

Hartford, CT · files as Virtus Investment Advisers, LLC
Know the moment Virtus Investment Advisers filesYou follow Virtus Investment Advisers An email or push as soon as its next 13F reaches the SEC, with every stock it bought, sold and trimmed. Next 13F due by Feb 15, 2027
Holdings as of Sep 30, 2026Filed Nov 12, 2026Next filing due Feb 15, 2027CIK 19481

Virtus Investment Advisers reported 458 stocks worth $453M in its 13F filing for Q3 2026, filed Nov 12, 2026. Its largest holdings are MRNA (1.4%), IOVA (1.4%) and REGN (0.9%). Compared with Q2 2026, the fund opened new positions in OKTA, HPE and PANW, added to MRNA, IOVA and REGN, trimmed MRVL, AMD and MU and sold out of ILMN, CAT and RCL.

Latest filing: what Virtus Investment Advisers did in Q3 2026

vs Q2 2026
Filed 13F-HRView on SEC ↗
45 new186 added225 trimmed50 sold outBought about $80.2M · sold about $62.9M
New 45
See all 45 →
Added 186
See all 186 →
Trimmed 225
  • DDOG−$1.6M−44%
  • DVN−$1.4M−40%
  • NTAP−$1.2M−34%
  • MU−$1.2M−33%
  • AMD−$734K−22%
See all 225 →
Sold out 50
See all 50 →

Dollar changes use the share change at the quarter end price. New and sold out show the whole position.

Reported value$453M+5.5% vs last quarter
Stocks held45845 new · 50 sold out
Top 5 weight5.5%spread out
Turnover49%of the portfolio changed

Portfolio at a glance

share of reported value · Q3 2026
🔒 A free account shows every holding, what the fund sold and its options.Create free account

Holdings

#StockValueWeightSharesChangeShares, 8 qtrsHeld
1
MRNA
Moderna Inc
$6.5M1.4%34K+10K (+45%)7 of 8
2
IOVA
Iovance Biotherapeutics Inc
$6.1M1.4%413K+128K (+45%)7 of 8
3
REGN
Regeneron Pharmaceutical
$4.2M0.9%5,490+1,170 (+27%)7 of 8
4
GILD
Gilead Sciences Inc
$4.1M0.9%28K+4,219 (+18%)7 of 8
5
AMGN
Amgen Inc
$4M0.9%9,586+1,014 (+12%)7 of 8
6
VRTX
Vertex Pharmaceuticals I
$4M0.9%7,668+5,054 (+193%)7 of 8
7
OMER
Omeros Corp
$3.7M0.8%193K+60K (+45%)5 of 8
8
INCY
Incyte Corp
$3.7M0.8%30K+633 (+2%)7 of 8
9
BMRN
Biomarin Pharmaceutical Inc
$3.6M0.8%61K+40K (+192%)7 of 8
10
VSTM
Verastem Inc
$3.3M0.7%411K+127K (+45%)4 of 8
🔒 448 more holdings in this filing. Create a free account or sign in to see them all.

Positions at Sep 30, 2026, as reported. Change is against the fund's Q2 2026 filing; weight is the share of the fund's reported stocks.

Sold out

held in Q2 2026, gone in Q3 2026
StockValue last quarterShares sold
ILMN
Illumina Inc
$2.5M14K
CAT
Caterpillar Inc
$2.3M2,173
RCL
Royal Caribbean Group
$2.2M6,961
HOOD
Robinhood Mkts Inc
$2.2M21K
URI
United Rentals Inc
$2.1M1,877

🔒 Free account: see all 30.

Reported value

last 8 quarters
$124MQ4 '24
$363MQ1 '25
$296MQ2 '25
$349MQ3 '25
$368MQ4 '25
$363MQ1 '26
$429MQ2 '26
$453MQ3 '26

The value of the US stocks the fund reported, at quarter end prices. It moves with the market as well as with buying and selling.

Filings for Q3 2026

straight from the SEC
FiledFormQuarter
Nov 12, 202613F-HRQ3 2026SEC filing ↗

Other superinvestors

All hedge fund holdings →

Virtus Investment Advisers 13F FAQ

What does Virtus Investment Advisers own?

Virtus Investment Advisers reported 458 stocks worth $453M in its 13F filing for Q3 2026, filed Nov 12, 2026. Its largest holdings are MRNA (1.4%), IOVA (1.4%) and REGN (0.9%). The table above lists every position in the filing (the top 10 without an account).

What did Virtus Investment Advisers buy and sell in Q3 2026?

Compared with Q2 2026: 45 new positions, 186 added to, 225 trimmed and 50 sold out. New positions include OKTA, HPE and PANW. It sold all of ILMN, CAT and RCL.

When will Virtus Investment Advisers file its next 13F?

Holdings as of Dec 31, 2026 are due by Feb 15, 2027. The filing appears on this page within minutes of reaching the SEC.

How much is Virtus Investment Advisers's portfolio worth?

The Q3 2026 filing reports $453M in US stocks. That leaves out cash, bonds, short positions and most foreign holdings, so the fund's total assets are usually larger.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Holdings come from the fund's SEC Form 13F filings as reported and show positions at the end of the quarter, up to 45 days before the filing. The fund may have changed its positions since. A 13F leaves out short positions, cash, bonds and most foreign holdings. See all hedge fund holdings.